402 related articles for article (PubMed ID: 38611065)
1. Oncogenic STAT Transcription Factors as Targets for Cancer Therapy: Innovative Strategies and Clinical Translation.
Wang W; Lopez McDonald MC; Hariprasad R; Hamilton T; Frank DA
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611065
[TBL] [Abstract][Full Text] [Related]
2. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention.
Buettner R; Mora LB; Jove R
Clin Cancer Res; 2002 Apr; 8(4):945-54. PubMed ID: 11948098
[TBL] [Abstract][Full Text] [Related]
3. Targeting the STAT pathway in head and neck cancer: recent advances and future prospects.
Nikitakis NG; Siavash H; Sauk JJ
Curr Cancer Drug Targets; 2004 Dec; 4(8):637-51. PubMed ID: 15578920
[TBL] [Abstract][Full Text] [Related]
4. The role of STATs in transcriptional control and their impact on cellular function.
Bromberg J; Darnell JE
Oncogene; 2000 May; 19(21):2468-73. PubMed ID: 10851045
[TBL] [Abstract][Full Text] [Related]
5. STAT proteins: novel molecular targets for cancer drug discovery.
Turkson J; Jove R
Oncogene; 2000 Dec; 19(56):6613-26. PubMed ID: 11426647
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers.
Brachet-Botineau M; Polomski M; Neubauer HA; Juen L; Hédou D; Viaud-Massuard MC; Prié G; Gouilleux F
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31963765
[TBL] [Abstract][Full Text] [Related]
7. Impact of STAT Proteins in Tumor Progress and Therapy Resistance in Advanced and Metastasized Prostate Cancer.
Ebersbach C; Beier AK; Thomas C; Erb HHH
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638338
[TBL] [Abstract][Full Text] [Related]
8. STATs in oncogenesis.
Bowman T; Garcia R; Turkson J; Jove R
Oncogene; 2000 May; 19(21):2474-88. PubMed ID: 10851046
[TBL] [Abstract][Full Text] [Related]
9. The genes induced by signal transducer and activators of transcription (STAT)3 and STAT5 in mammary epithelial cells define the roles of these STATs in mammary development.
Clarkson RW; Boland MP; Kritikou EA; Lee JM; Freeman TC; Tiffen PG; Watson CJ
Mol Endocrinol; 2006 Mar; 20(3):675-85. PubMed ID: 16293640
[TBL] [Abstract][Full Text] [Related]
10. Activation of STAT transcription factors by the Rho-family GTPases.
Corry J; Mott HR; Owen D
Biochem Soc Trans; 2020 Oct; 48(5):2213-2227. PubMed ID: 32915198
[TBL] [Abstract][Full Text] [Related]
11. STAT signaling in the pathogenesis and treatment of cancer.
Frank DA
Mol Med; 1999 Jul; 5(7):432-56. PubMed ID: 10449805
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer.
Haura EB; Turkson J; Jove R
Nat Clin Pract Oncol; 2005 Jun; 2(6):315-24. PubMed ID: 16264989
[TBL] [Abstract][Full Text] [Related]
13. Advances in peptidic and peptidomimetic-based approaches to inhibit STAT signaling in human diseases.
Szelag M; Wesoly J; Bluyssen HA
Curr Protein Pept Sci; 2016; 17(2):135-46. PubMed ID: 26521960
[TBL] [Abstract][Full Text] [Related]
14. The complementary roles of STAT3 and STAT1 in cancer biology: insights into tumor pathogenesis and therapeutic strategies.
Wang W; Lopez McDonald MC; Kim C; Ma M; Pan ZT; Kaufmann C; Frank DA
Front Immunol; 2023; 14():1265818. PubMed ID: 38022653
[TBL] [Abstract][Full Text] [Related]
15. STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges.
Wong GL; Manore SG; Doheny DL; Lo HW
Semin Cancer Biol; 2022 Nov; 86(Pt 3):84-106. PubMed ID: 35995341
[TBL] [Abstract][Full Text] [Related]
16. STAT signaling in glioma cells.
Swiatek-Machado K; Kaminska B
Adv Exp Med Biol; 2013; 986():189-208. PubMed ID: 22879070
[TBL] [Abstract][Full Text] [Related]
17. STAT proteins as novel targets for cancer therapy. Signal transducer an activator of transcription.
Catlett-Falcone R; Dalton WS; Jove R
Curr Opin Oncol; 1999 Nov; 11(6):490-6. PubMed ID: 10550013
[TBL] [Abstract][Full Text] [Related]
18. Signal transducers and activators of transcription (STATs): Novel targets of chemopreventive and chemotherapeutic drugs.
Klampfer L
Curr Cancer Drug Targets; 2006 Mar; 6(2):107-21. PubMed ID: 16529541
[TBL] [Abstract][Full Text] [Related]
19. JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies.
Rah B; Rather RA; Bhat GR; Baba AB; Mushtaq I; Farooq M; Yousuf T; Dar SB; Parveen S; Hassan R; Mohammad F; Qassim I; Bhat A; Ali S; Zargar MH; Afroze D
Front Pharmacol; 2022; 13():821344. PubMed ID: 35401182
[TBL] [Abstract][Full Text] [Related]
20. Signal Transducers and Activators of Transcription: Novel Targets for Anticancer Therapeutics.
Bowman T; Yu H; Sebti S; Dalton W; Jove R
Cancer Control; 1999 Oct; 6(5):427-435. PubMed ID: 10758575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
